1. Home
  2. Analysis
  3. Bronchopulmonary-dysplasia

Bronchopulmonary dysplasia: treatments, associated drugs and conditions

Summary:

Bronchopulmonary dysplasia: chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type.

We study 2,698 people who have Bronchopulmonary dysplasia. The information that eHealthMe analyzes includes:

- Medications that treat Bronchopulmonary dysplasia and their effectiveness
- 113 drugs that are associated with Bronchopulmonary dysplasia


Number of reports submitted per year:

Bronchopulmonary dysplasia: 2,698 reports.

Bronchopulmonary dysplasia treatments and how effective are they?

All the drugs that are associated with Bronchopulmonary dysplasia:

Do you take any medication?

- You can use our AI-powered tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all conditions on eHealthMe.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.